Approval · Notice of Compliance 23083 · 2020
HALAGON: Notice of Compliance 23083
Issued January 8, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23083
- Date
- January 8, 2020
- Company
- Emdoka BvbaHoogstraten, Antwerpen, Belgium
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Manufcturing change
- Canadian reference product
- HALOCUR (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALAGON | 02475766 | Marketed |
Medicinal ingredients
- HALOFUGINONE LACTATE 0.5 MG per ML